TITLE

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry

PUB. DATE
January 2008
SOURCE
BMC Genomics;2008 Supplement 2, Vol. 9, p541
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43775145

 

Related Articles

  • Proteomic profiling of cancer biomarkers. Hungyi Shau; Chandler, G. Scott; Whitelegge, Julian P.; Gornbein, Jeffrey A.; Faull, Kym F.; Chang, Helena R. // Briefings in Functional Genomics & Proteomics;Jul2003, Vol. 2 Issue 2, p147 

    Provides an overview of the cancer biomarker discovery process from the proteomic profiling point of view. Emphasis given to the principles that are involved in the process; Protein identification strategies; Information on surface enhanced laser desorption ionization mass spectrometry.

  • Shimadzu introduces the first LCMS-IT-TOF Mass Spectrometer.  // LC-GC Europe;Oct2005 Supplement, p11 

    Introduces the LCMS-IT-TOF mass spectrometer, a combination of two different mass spectrometry techniques developed by Shimadzu Corp. in Kyoto, Japan. Information on the process of the spectrometer; Capabilities of the mass spectrometer in biomarker discovery, metabolite identification and human...

  • Accurate mass tag retention time database for urine proteome analysis by chromatography-mass spectrometry. Agron, I. A.; Avtonomov, D. M.; Kononikhin, A. S.; Popov, I. A.; Moshkovskii, S. A.; Nikolaev, E. N. // Biochemistry (00062979);May2010, Vol. 75 Issue 5, p636 

    Information about peptides and proteins in urine can be used to search for biomarkers of early stages of various diseases. The main technology currently used for identification of peptides and proteins is tandem mass spectrometry, in which peptides are identified by mass spectra of their...

  • Biomarker Discovery of Pancreatic and Gastrointestinal Cancer by 2DICAL: 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry. Ono, Masaya; Kamita, Masahiro; Murakoshi, Yusuke; Matsubara, Junichi; Honda, Kazufumi; Miho, Banno; Sakuma, Tomohiro; Yamada, Tesshi // International Journal of Proteomics;2012, p1 

    Biomarkers tested by blood sample are of great use to clinicians as they provide useful information to aid an early and accurate diagnosis. Comprehensive "omics" studies are expected to facilitate the identification of such new biomarkers, and much research is being performed in this area. Our...

  • LC/MS System IDs Proteins and Biomarkers.  // Bio-IT World;Jul2004, Vol. 3 Issue 7, p56 

    Evaluates the Advanced Liquid Chromatography/Mass Spectrometry Protein Identification System from Agilent Technologies. Protocols for identification of proteins and biomarkers provided by the system; Design of the device; Information on the optimized method protocols of the system.

  • Protein mass spectra data analysis for clinical biomarker discovery: a global review. Roy, Pascal; Truntzer, Caroline; Maucort-Boulch, Delphine; Jouve, Thomas; Molinari, Nicolas // Briefings in Bioinformatics;Mar2011, Vol. 12 Issue 2, p176 

    The identification of new diagnostic or prognostic biomarkers is one of the main aims of clinical cancer research. In recent years there has been a growing interest in using high throughput technologies for the detection of such biomarkers. In particular, mass spectrometry appears as an exciting...

  • Invention & Innovation Go Hand-in-Hand with Mass Spectrometry. Schu, Bill // Genomics & Proteomics;May2005, Vol. 5 Issue 4, p12 

    Focuses on the efforts by life science researchers to push the outer limits of mass spectrometry. Advantages of traditional mass spectrometers to researchers in biomarker discovery; Costs of using antibody arrays as a powerful tool in proteomics; Use of mass spectrometry for protein...

  • Biomarker Detection Using Protein Arrays. Koppal, Tanuja // Drug Discovery & Development;Dec2002, Vol. 5 Issue 11, p35 

    Discusses the growing use of protein microarrays in detecting and identifying protein biomarkers for toxicology and early diagnosis of diseases. Detection of novel protein biomarkers through mass spectrometry; Identification of novel biomarkers through toxicological profiles of biochemical...

  • AB Sciex and ARUP Laboratories Collaborate MS Identifies Hepatitis E Biomarkers.  // Spectroscopy;Mar2011, Vol. 26 Issue 3, p14 

    The article discusses the collaboration of AB Sciex Pte Ltd. and Arup Laboratories Inc. in the U.S. and the identification of hepatitis E biomarkers in India. The collaboration of AB Sciex and Arup is intended to develop new test methods to improve hormone analysis using mass spectrometry (MS)....

  • Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches. Suehara, Yoshiyuki; Kubota, Daisuke; Kikuta, Kazutaka; Kaneko, Kazuo; Kawai, Akira; Kondo, Tadashi // Sarcoma;2012, p1 

    Osteosarcomas are the most common malignant bone tumors, and the identification of useful tumor biomarkers and target proteins is required to predict the clinical outcome of patients and therapeutic response as well as to develop novel therapeutic strategies. Global protein expression studies,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics